London Biotechnology Show

Home
United Kingdom
London
London Biotechnology Show

Unlocking The Potential of Biotechnology For Revolutionising Medical & Healthcare Sectors Globally | 18 - 19 June 2025 | ExCeL London

16/06/2026

Every breakthrough in biotechnology brings us closer to a healthier, more sustainable future.

This 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐃𝐚𝐲, we recognise the researchers, innovators, startups, and industry leaders whose work continues to redefine medicine, diagnostics, therapeutics, and patient care.

London Biotechnology Show 2026 will bring together the minds and organisations driving this progress, creating opportunities for collaboration, investment, and knowledge exchange across the global life sciences ecosystem.

Be part of the conversation this November.

Register today: https://londonbiotechshow.com/register?utm_campaign=Social+media&utm_medium=others&utm_source=others

15/06/2026

We are pleased to welcome Engivent as a Startup Exhibitor at the London Biotechnology Show 2026.

Engivent delivers closed-loop automation to streamline protein and enzyme engineering. Its modular platform integrates robotics and microfluidics for high-throughput optimisation of expression, purification, and characterization, reducing cost, reagent use, and iteration time. Ideal for therapeutic discovery and bioassay development, directed evolution from individual enzymes to whole-microbe screening, with expression from a range of hosts or cell-free production, its systems provide a path to scalable, standardized wet-lab experimentation.

Join innovative startups like Engivent and showcase your solutions to a global audience of biotech leaders, investors, researchers, and decision-makers.

Take advantage of our 𝐋𝐨𝐧𝐝𝐨𝐧 𝐒𝐮𝐦𝐦𝐞𝐫 𝐒𝐚𝐯𝐢𝐧𝐠𝐬 and save 𝟐𝟎% 𝐨𝐧 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐨𝐫 & 𝐒𝐩𝐨𝐧𝐬𝐨𝐫𝐬𝐡𝐢𝐩 𝐏𝐚𝐜𝐤𝐚𝐠𝐞𝐬 for a limited time.

Secure your spot today: https://londonbiotechshow.com/register?t=exhibitor&utm_campaign=socialmedia&utm_medium=others&utm_source=others

10/06/2026

Turning scientific innovation into commercial success requires more than breakthrough research. It requires the right connections, visibility, and opportunities.

At the London Biotechnology Show 2026, startups gain access to investors, industry leaders, potential partners, and decision-makers from across the global biotechnology ecosystem.

Whether you are seeking funding, strategic collaborations, market insights, or industry exposure, LBS26 provides a platform designed to help biotech startups accelerate their growth journey.

Book your spot today https://londonbiotechshow.com/register?t=exhibitor&utm_campaign=Social+media&utm_medium=others&utm_source=others and connect with the people who can help take your innovation further.

08/06/2026

We are pleased to recognise some of the media partners helping foster industry dialogue across biotechnology, cell & gene therapy, RNA therapeutics, laboratory sciences, and medical technology.

• Cell & Gene
• Advancing RNA
• Laboratory
• Med Device Online

Through their publications and communities, these platforms contribute to the exchange of ideas, insights, and innovations shaping the future of life sciences.

Be part of the conversations driving the biotechnology industry forward.

Secure your spot today: https://londonbiotechshow.com/register?utm_campaign=Social+media&utm_medium=others&utm_source=others

04/06/2026

We are pleased to welcome Matt Simmons, Therapeutic Strategy Lead at IQVIA Biotech, to the speaker lineup at the London Biotechnology Show 2026.

With 30 years of experience spanning Large Pharma, CROs, consulting and software companies, across all phases of drug development, as well as running the UK’s leading independent early phase cancer clinical trials unit, Matt supporting biotech clients build impact from innovation through identifying and understanding their needs, translating these to operational strategies, and working with multi-functional teams in delivering on their expectations.

Join Matt and other industry leaders as they explore the innovations, strategies, and collaborations shaping the future of biotechnology.

Secure your delegate pass today and save 20% on Individual Passes or 40% on Group Delegate Passes: https://londonbiotechshow.com/register?t=delegate&utm_campaign=Social+media&utm_medium=others&utm_source=others

02/06/2026

London Summer Savings are now live.

For a limited time, organisations can unlock a flat 20% saving on Exhibition & Sponsorship Packages at the London Biotechnology Show 2026.

This is an opportunity to position your organisation alongside global biotech, pharma, MedTech, diagnostics, and healthcare leaders at one of the UK’s leading biotechnology platforms taking place at Excel London this November.

Whether your objective is investor engagement, brand visibility, lead generation, partnership development, or showcasing innovation, LBS26 offers direct access to high-value industry connections and commercial opportunities.

Secure your stand now https://londonbiotechshow.com/register?t=exhibitor&utm_campaign=Social+media&utm_medium=others&utm_source=others and take advantage of this exclusive summer offer before it closes.

01/06/2026

We are pleased to welcome Validated Cloud as an exhibitor at the London Biotechnology Show 2026.

Validated Cloud is a purpose-built, GxP-qualified hosting platform designed exclusively for life science organizations. The company runs the infrastructure, security, and compliance layers that FDA, EMA, and MHRA regulated systems require, enabling partners and clients to avoid building or qualifying cloud environments themselves. Its team comes from life sciences, bringing a deep understanding of the regulations, terminology, and expectations of audits and inspectors.

Validated Cloud operates as a “quality company that does hosting,” providing qualified infrastructure, managed services, and independent quality oversight. This allows pharma, biotech, med-device companies, CROs, and regulated SaaS vendors to deploy faster, reduce internal workload, and maintain confidence that their platforms meet 21 CFR Part 11, Annex 11, ISO 9001/27001, HIPAA, GDPR, and other requirements.

By providing a compliant infrastructure foundation, Validated Cloud enables its partners and clients to focus on advancing their science, systems, and data.

Join us at Excel London this November and connect with the innovators, technology providers, investors, and industry leaders shaping the future of biotechnology and healthcare.

Book your stand now: https://londonbiotechshow.com/register?t=exhibitor&utm_campaign=Social+media&utm_medium=others&utm_source=others

25/05/2026

The right connections can accelerate partnerships, investment opportunities, and commercial growth across the biotechnology ecosystem.

The Buyer Programme at the London Biotechnology Show 2026 is designed to connect exhibitors with pre-qualified senior decision-makers through curated meetings, strategic networking, and focused business engagement.

From biotech and pharmaceutical companies to healthcare providers, investors, CROs, research institutions, and regulatory bodies, the programme is built to facilitate meaningful industry connections and measurable business outcomes.

If your organisation is actively seeking innovation partners, technologies, investment opportunities, or strategic collaborations, this is where those conversations begin.

Apply for the Buyer Programme Today: https://londonbiotechshow.com/register/?t=buyer-programme&utm_campaign=Social+media&utm_medium=others&utm_source=others

22/05/2026

We are pleased to welcome Tom Smith, Strategic Director, Cell and Gene Therapies at Uniphar Group, to the speaker lineup at the London Biotechnology Show 2026.

Tom has over 7 years’ experience with expanded access programs partnering with biotech and pharma companies. During this time, Tom has led the development of a robust cell and gene platform to maximise patient access to cell and gene therapies globally. Within Uniphar, Tom’s role is focused on the delivery of strategic projects, collaborating with partners on their EAP strategy while driving innovation in the cell and gene space. Tom has been instrumental in Uniphar’s delivery of over 10 Cell & Gene Therapies to over 650 patients worldwide and has vast experience in navigating the complex scientific, regulatory, and operational challenges that are present in the delivery of cell and gene therapies.

Be part of the conversations shaping the future of advanced therapeutics, patient access, and biotechnology innovation this November at Excel London.

Secure your delegate pass today: https://londonbiotechshow.com/register?t=delegate&utm_campaign=Social+media&utm_medium=others&utm_source=others

21/05/2026

Cold Chain Platform (CCP) Joins the 3rd Edition of the London Biotechnology Show as a Media Partner.

Cold Chain Platform (CCP) is a global information provider specializing in cold chain and logistics for the pharmaceutical industry. CCP offers a comprehensive directory of packaging, monitoring, logistics, GXP, and consulting providers, along with industry news, articles, interviews, and events.

CCP supports pharmaceutical companies in accessing ideal cold chain and logistics partners, as well as valuable resources for supply chain management at every stage—from clinical trials to commercial distribution—connecting people, fostering collaborations and creating meaningful synergies.

Visit https://londonbiotechshow.com/register?utm_campaign=Social+media&utm_medium=others&utm_source=others to secure your spot today.

Address

Clarence Centre 6 St. George's Circus
London

Website

https://biotechnologyshow.com/

Alerts

Be the first to know and let us send you an email when London Biotechnology Show posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to London Biotechnology Show:

Shortcuts

Want your business to be the top-listed Business in London?